TScan Therapeutics (TCRX) Treasury Shares (2020 - 2021)

TScan Therapeutics' (TCRX) quarterly Treasury Shares came in at $116870.0 in Q4 2021, down 98.35% year-on-year from $7.1 million in Q4 2020, and down 42.85% on a QoQ basis from $204513.0 in Q3 2021.

TScan Therapeutics (TCRX) Treasury Shares (2020 - 2021) Analysis & Trends

TScan Therapeutics (TCRX) has 2 years of Treasury Shares data on file, last reported at $116870.0 in Q4 2021.

  • On a quarterly basis, Treasury Shares fell 98.35% year-over-year to $116870.0 in Q4 2021; TTM through Dec 2021 was $116870.0, a 98.35% decrease from a year earlier, with the FY2021 full-year figure at $116870.0, down 98.35% from the prior year.
  • Treasury Shares for Q4 2021 stood at $116870.0, down from $204513.0 in the prior quarter.
  • Over the last five years, Treasury Shares for TCRX reached as high as $15.6 million in Q1 2021 and fell as low as $116870.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -21,709.08
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 265,401.92
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 19.41 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 5.14 Mn
10 TScan Therapeutics 100.59 Mn -27.47 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 116,870.00
Dec 31, 2021 116,870.00
Sep 30, 2021 204,513.00
Sep 30, 2021 204,513.00
Jun 30, 2021 15.62 Mn
Jun 30, 2021 15.62 Mn
Mar 31, 2021 15.62 Mn
Mar 31, 2021 15.62 Mn
Dec 31, 2020 7.06 Mn
Dec 31, 2020 7.06 Mn
Sep 30, 2020 7.06 Mn
Sep 30, 2020 7.06 Mn
Jun 30, 2020 7.06 Mn
Jun 30, 2020 7.06 Mn